Clinical Trial Update: Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating propranolol to modulate opioid-induced hyperalgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Hyperalgesia

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Hyperalgesia | Phase 4 | Status: UNKNOWN